Aging cellOct 28, 2026

Aging Support Cells May Cause Stem Cell Aging by Producing Imbalanced Signaling Molecules

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Nov 2, 2026

Abstract

Dysregulated chemokine synthesis in aged mesenchymal stromal cells (MSCs) may link MSC aging to declining regenerative capacity.

Aging is associated with a decline in the regenerative capacity of tissues due to stem cell dysfunction.
MSCs play a crucial role in regulating stem cell behavior by integrating various signals from their environment.
With age, MSCs experience functional decline and senescence, leading to altered signaling and secretory profiles.
Senescence in MSCs is linked to increased chronic inflammation and chemokine imbalance, which can negatively impact stem cell support.
Age-related stressors may promote MSC senescence, exacerbating the loss of regenerative potential.
Therapeutic approaches targeting chemokine signals and rejuvenating MSCs could potentially restore regenerative capacity.

Simplified

Aging is accompanied by a progressive decline in tissue regenerative capacity, driven by intrinsic stem cell dysfunction and age-associated deterioration of the surrounding stem cell niche. Mesenchymal stromal cells (MSCs) are ubiquitous components of stem cell niches, where they integrate structural, metabolic, inflammatory, and paracrine cues to regulate stem cell quiescence, activation, and differentiation. With age, MSCs undergo functional decline and senescence, altering their secretory and signaling profiles. Across tissues, MSC senescence emerges as an intermediate amplifier of aging: molecular, metabolic, epigenetic, and inflammatory stressors promote the senescent state, which converts these upstream insults into chemokine imbalance, chronic inflammation, and progressive loss of stem cell support. Here, we synthesize classical and emerging literature to examine how age-associated changes in MSC chemokine synthesis contribute to stem cell aging, and we propose a synthesis-based model in which MSCs translate age-associated stressors into altered chemokine repertoires that disrupt stem cell-supportive signaling. We also discuss therapeutic strategies, including chemokine-directed therapies, senolytics, and MSC rejuvenation, that may restore regenerative capacity by normalizing MSC-derived signals. Together, the evidence identifies dysregulated chemokine synthesis as a conserved mechanism linking tissue-resident MSC aging to declining regenerative capacity.

Full Text

Full text is available at the source.

View Full Text ↗

Aging Support Cells May Cause Stem Cell Aging by Producing Imbalanced Signaling Molecules

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the longevity & aging brief